Ultra-LEAF™ Purified anti-human CD279 (PD-1) Antibody

Product Details

Verified Reactivity

Human

Antibody Type

Monoclonal

Host Species

Mouse

Immunogen

Recombinant human CD279 protein

Formulation

0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative. Endotoxin level is <0.01 EU/µg of the protein (<0.001 ng/µg of the protein) as determined by the LAL test.

Preparation

The Ultra-LEAF™ (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.

Concentration

The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. Older lots may have also been bottled at 1 mg/mL. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF™ solution contains no preservative; handle under aseptic conditions.

Application

Block - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by blocking hPD-1 and hPD-L1 binding in the presence of 0.8 µg/mL hPD-1 Biotin. ND₅₀ range: 0.1– 0.5 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

A17188B antibody can block the binding of NAT105 and EH12.2H7 antibodies to the target.

RRID

AB_2820104 (BioLegend Cat. No. 621603)
AB_2820105 (BioLegend Cat. No. 621604)

Antigen Details

Structure

55 kD type I transmembrane protein

Distribution

Transiently expressed on CD4- and CD8- thymocytes, upregulated in thymocytes and splenic T and B lymphocytes, and is expressed on activated myeloid cells.

Function

Signaling and co-stimulation (co-inhibition)

Interaction

SHP-1 and SHP-2

Ligand/Receptor

PD-L1 (CD274) and PD-L2 (CD273)

Cell Type

Lymphocytes, T cells

Biology Area

Cell Biology, Immuno-Oncology, Inhibitory Molecules

Molecular Family

CD Molecules

Antigen References

1. Ishida Y, et al. 1992. EMBO J. 11:3887
2. Francisco LM, et al. 2010. Immunol Rev. 236:219

Gene ID

5133 View all products for this Gene ID

UniProt

View information about CD279 on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Material Safety Data Sheet

Reviews

Related Pages & Pathways

Related FAQs

Do you guarantee that your antibodies are totally pathogen free?

BioLegend does not test for pathogens in-house aside from the GoInVivo™ product line. However, upon request, this can be tested on a custom basis with an outside, independent laboratory.

Does BioLegend test each Ultra-LEAF™ antibody by functional assay?

No, BioLegend does not test Ultra-LEAF™ antibodies by functional assays unless otherwise indicated. Due to the possible complexities and variations of uses of biofunctional antibodies in different assays and because of the large product portfolio, BioLegend does not currently perform functional assays as a routine QC for the antibodies. However, we do provide references in which the antibodies were used for functional assays and we do perform QC to verify the specificity and quality of the antibody based on our strict specification criteria.

Does BioLegend test each Ultra-LEAF™ antibody for potential pathogens?

No, BioLegend does not test for pathogens in-house unless otherwise indicated.  However, we can recommend an outside vendor to perform this testing as needed.

Have you tested this Ultra-LEAF™ antibody for in vivo or in vitro applications?

We don't test our antibodies for in vivo or in vitro applications unless otherwise indicated. Depending on the product, the TDS may describe literature supporting usage of a particular product for bioassay. It may be best to further consult the literature to find clone specific information.

Other Formats

Certificate of Analysis